BioSpace News Archive

Opioid analgesics increase the risk of pneumonia among persons with Alzheimer’s disease

Opioid analgesics were associated with a 30% increase in the risk of pneumonia in persons with Alzheimer’s disease, a recent study from the University of Eastern Finland shows.

June 4, 2019
·
2 min read
Drug Development

Minoryx Therapeutics announces first patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia

Minoryx Therapeutics announces that the first patient has been dosed with its lead candidate, leriglitazone, in the phase 2 FRAMES clinical trial in Friedreich’s Ataxia.

June 4, 2019
·
4 min read
Business

Genedata Expressionist® 13.0 Streamlines In-depth Characterization and Automates Quality Monitoring of Biopharmaceuticals

Latest release of enterprise software solution that enhances efficiency of biopharmaceutical development with special focus on supporting Multi-Attribute Methods (MAM) showcased at 2019 ASMS

June 4, 2019
·
4 min read
Biotech Bay

Bioz Launches the Next-Generation of Its Industry-Leading AI Search Engine for Life Science Experimentation

New AI Platform Accelerates Scientific Research and Drug Discovery, includes over 300 Million Product Listings from 50,000 Vendors

June 4, 2019
·
7 min read
From Fly-Over to “Fly-To” Country: BioSTL Attracts International Health Care Innovators to St. Louis

The GlobalSTL Health Innovation Summit brings new international technologies to local health care systems to create competitive advantage and economic impact in St. Louis

June 4, 2019
·
7 min read
Drug Development

Genentech’s Xofluza Effective at Preventing Flu After Household Exposure in Clinical Trial

Xofluza showed a significant preventive effect after a single oral dose. Only about 1.9% of patients who received Xofluza showed signs of the flu, compared to 13.6% of the placebo group.

June 4, 2019
·
2 min read
·
Mark Terry
Business

Update: Nearly 12 Million Patients Fall Victim to Quest Diagnostics’ Data Breach

Information exposed in the hacking includes financial data, Social Security numbers and medical information, Quest said.

June 4, 2019
·
4 min read
·
Alex Keown
Biotech Bay

Continued Dosing of Peanut Allergy Therapy Leads to Greater Tolerance, Trial Data Shows

The add-on data showed that longer treatment with AR101 provided higher tolerance levels to peanut protein.

June 4, 2019
·
2 min read
·
Alex Keown
Business

Abveris and TetraGenetics Announce Antibody Discovery Collaboration

Abveris, Inc., a leader in contract research antibody discovery, announced that it has entered into a multi-target agreement with TetraGenetics, Inc.

June 4, 2019
·
2 min read
Drug Development

Braeburn Announces Publication of Phase 3 Study Results Showing Long-term Safety and Effectiveness of BRIXADI™ (buprenorphine) Extended-Release Injection for the Treatment of Opioid Use Disorder

Braeburn Inc. announces the publication of its 48-week, open-label, multi-center, global Phase 3 long-term safety study of once weekly and once monthly BRIXADI in a leading substance use disorder journal, Addiction.

June 4, 2019
·
4 min read